Pfizer: Shares Stabilize At $25 As Establishments Start To Load Up (NYSE:PFE)
This text was written byComply withSmall deep worth particular person investor, with a modest non-public funding portfolio, cut up approx. ...
Friday, April 25, 2025
Tag: NYSEPFE
Pfizer Stays A Good Decide For Dividend Buyers (NYSE:PFE)
This text was written byComply withMy evaluation is targeted on high-quality firms, that may outperform the market over the long-run ...
Pfizer Inventory’s 2025 Comeback: What’s Driving Progress (NYSE:PFE)
This text was written byObserveYiannis Zourmpanos, founding father of Yiazou IQ, an AI-driven inventory analysis platform offering all-in-one inventory experiences. ...
Pfizer: Development From Oncology Franchise; Provoke With ‘Purchase’ (NYSE:PFE)
This text was written byObserveGreater than 15 years {of professional} funding expertise in international equities throughout all sectors. My funding ...
Pharma companies dominate list of innovation leaders thanks to patents (NYSE:PFE)
MF3d A new report examining innovation found that among the 100 most innovative companies, the largest number -- 18 -- ...
Credit Suisse says large cap biopharma offers defense in macro storm (NYSE:PFE)
Oleg Elkov Citing historical performance and fundamentals, Credit Suisse identified U.S. large-cap biopharma as an attractive defensive pocket amid lingering ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.